The Vall d'Hebron University Hospital is a public and university affiliated hospital founded in 1955. It belongs to the Catalan Health Institute and is the hospital complex with the highest volume of interventions in Catalonia, Spain.

There are 1,146 beds in Hospital Universitari Vall dHebron; Oncology.

During the past decade, Hospital Universitari Vall dHebron; Oncology conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 10 clinical trials were completed, i.e. on average, 35.7% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 10 clinical trials were completed. i.e. 111.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Universitari Vall dHebron; Oncology" #1 sponsor was "Hoffmann-La Roche" with 16 trials, followed by "EMD Serono Research & Development Institute, Inc." with 8 trials sponsored, "Pfizer" with 2 trials sponsored, "Genentech, Inc." with 1 trials sponsored and "Merck KGaA, Darmstadt, Germany" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitari Vall dHebron; Oncology" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 8 trials as a collaborator, "BioLineRx, Ltd." with 1 trials as a collaborator, "Celgene" with 1 trials as a collaborator, "Halozyme Therapeutics" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitari Vall dHebron; Oncology" are "Non-small Cell Lung Cancer" (5 trials), "Biliary Tract Cancer" (4 trials), "Carcinoma, Hepatocellular" (2 trials), "Cholangiocarcinoma" (2 trials) and "Gallbladder Cancer" (2 trials). Many other conditions were trialed in "Hospital Universitari Vall dHebron; Oncology" in a lesser frequency.

Most popular intervention types in "Hospital Universitari Vall dHebron; Oncology" are "Drug" (28 trials), "Other" (3 trials), "Radiation" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (13 trials), "Cisplatin" (9 trials), "Carboplatin" (7 trials), "Gemcitabine" (7 trials) and "Placebo" (7 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitari Vall dHebron; Oncology" are 24 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Universitari Vall dHebron; Oncology". undefined are not yet recruiting, 6 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Hospital Universitari Vall dHebron; Oncology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitari Vall dHebron; Oncology, 7 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".